Affymetrix’s GeneChip tapped by genetic researchers

Sept. 24, 2004 – Industrial and academic researchers are using microarray-based technology developed by Affymetrix Inc. to study the causes of cancer and other diseases, according to news releases.

The Santa Clara, Calif.-based company’s GeneChip systems will be used by the Broad Institute of the Massachusetts Institute of Technology and Harvard University to study the genetic causes of diseases and discover the molecular signatures of disease and drug response. A release said the GeneChip High Throughput system automates the most labor-intensive steps in microarray processing, and will give researchers the “massive-scale” capability they need to study complex biological problems.


Perlegen Sciences, an Affymetrix spinoff, is using the microarrays to study the genetic causes of Alzheimer’s disease, autism and Parkinson’s disease. The technology enables scientists to cost-effectively analyze whole genomes with sufficient resolution to identify the genetic variations that could play a role in these diseases, a release said.


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.